A Powerful Weapon against Opioids
Buprenorphine is a drug that has had considerable success in the treatment of opioid dependency. It is commonly used in medication-assisted treatment (MAT) programs and should be taken in combination with counseling and 12-step recovery. Approved by the Food and Drug Administration in 2002, buprenorphine is an opioid antagonist. This means it produces less severe effects of more harmful opiates and opioids like heroin and prescription painkillers, helping to reduce and eliminate cravings. Buprenorphine is the first medication to treat opioid dependency that is permitted to be prescribed or dispensed in physician offices, significantly increasing treatment access.
Buprenorphine is sold under the following brand-name medications:
- Suboxone – (Buprenorphine and Naloxone) Film or Tablet
- Subutex – (Pure Buprenorphine) Tablet
- Naloxone (Buprenorphine and Baloxone) Buccal Film
- Zubslov (Buprenorphine and Naloxone) Sublingual Tablet
Who is Eligible for Buprenorphine?
The first step in any medication-assisted treatment process is consulting your physician and treatment professional to see if you are eligible. While buprenorphine is an effective treatment resource, it can also be habit forming. Each stage of the process should be closely monitored by the prescribing physician, including any changes in amount or frequency of dosage.
Buprenorphine is recommended for patients who:
- Have been objectively diagnosed with an opioid dependency
- Are willing to follow safety precautions for the treatment
- Have been cleared of any health conflicts with using buprenorphine
- Have reviewed other treatment options before agreeing to buprenorphine treatment
Each person’s addiction care needs are different, which is why individual screening must take place before buprenorphine is prescribed.